|
||||||||||||||||||||||||||||||||||||
| [
Contents
] [ INDEX ]
|
||||||||||||||||||||||||||||||||||||
| UDK 616.441-002-07 |
ISSN 035-2899, 39(2014) br.4 p.219-223 |
|||||||||||||||||||||||||||||||||||
|
Case report Atypical subacute thyroiditis and functional thyroid adenoma – Case report (Atipični subakutni tiroiditis i funkcijski adenom tiroidee – prikaz slučaja) Željka Aleksić (1), Nenad Ristović (2), Aleksandar Aleksić (3) (1) Služba za nuklearnu medicinu, Zdravstveni centar Zaječar, (2) Infektološka služba, Zdravstveni centar Zaječar, (3) Internistička služba, Zdravstveni centar Zaječar |
||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||
| Download in pdf format | Extended summary:
Subacute thyroiditis (SAT), also known as DeQuervain's or
granulomatous thyroiditis is an inflammatory condition of the
thyroid gland, which is usually fully affected. Severe pain and
tenderness in the thyroid bed occur typically and are followed by
weakness, fatigue, pain in muscles and joints, and light to moderate
fever and symptoms of thyrotoxicosis - nervousness, sweating and
rapid heartbeat and trembling. Temporary elevated serum thyroxine,
suppressed TSH and elevated serum markers of inflammation in the
acute phase are pathognomonic for the SAT, with diffusely absent
binding of radioactive iodine or technetium-pertechnetate in the
thyroid gland due to thyrocytes destruction. Rare cases of atypical
SAT - painless or with minimal pain, SAT limited to one thyroid lobe
or focal thyroiditis, are reported in literature. We report a rare
case of a minimally painful SAT associated with functional adenoma
in the right lobe of the thyroid gland, which was, in thyrotoxic,
acute phase, scintigraphicaly presented as toxic adenoma, in fact
representing a functional adenoma tissue unaffected by destructive
thyroiditis. Keywords: atypical subacute thyroiditis, autonomously functioning thyroid nodule, toxic adenoma Napomena: kompletan tekst rada na srpskom jeziku Note: full text in Serbian |
|||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||
|
Corresponding Address: Željka Aleksić Služba za nuklearnu medicinu, Zdravstven Centar Zaječar, Rasadnička bb, 19 000 Zaječar, Srbija; E-mail: lukaal@open.telekom.rs |
Paper received: 31.8.2014 Paper accepted: 31.8.2014 Paper Internet issues: 17.11.2014 |
|||||||||||||||||||||||||||||||||||
| [
Contents
] [ INDEX ]
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
